Andrew Guggenhime - Journey Medical CFO and COO
| DERM Stock | USD 3.40 0.14 3.95% |
COO
Mr. Andrew L. Guggenhime is Chief Financial Officer of the Company. He has served as our Chief Financial Officer since April 2014. Mr. Guggenhime also served as our Chief Operating Officer from April 2014 until May 2018. From September 2011 to April 2014, Mr. Guggenhime served as Chief Financial Officer for CardioDx, Inc., a molecular diagnostics life sciences company, and as a member of the CardioDx board of directors from April 2014 until July 2016. From September 2010 to April 2011, Mr. Guggenhime served as Chief Financial Officer for Calistoga Pharmaceuticals, Inc., a biotechnology company acquired in April 2011 by Gilead. From December 2008 to June 2010, Mr. Guggenhime served as Senior Vice President and Chief Financial Officer for Facet Biotech Corporationrationration, a biotechnology company acquired in April 2010 by Abbott Laboratories. Facet Biotech Corporation was spun off from PDL BioPharma, Inc., a biopharmaceutical company, at which Mr. Guggenhime served as Chief Financial Officer from April 2006 to December 2008. From October 2000 to March 2006, Mr. Guggenhime served as Senior Vice President and Chief Financial Officer for Neoforma, Inc., a provider of supplychain management solutions for the healthcare industry, and from January to October 2000 he served as its Vice President, Corporationrationrate Development. Mr. Guggenhime began his career in financial services at Merrill Lynch Co. and Wells Fargo Company. He currently serves on the board of directors of Metacrine, Inc., a privately held biotechnology company since 2018.
| Age | 48 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Address | 9237 East Via de Ventura Boulevard, Scottsdale, AZ, United States, 85258 |
| Phone | 480 434 6670 |
| Web | https://journeymedicalcorp.com |
Journey Medical Management Efficiency
As of the 25th of April 2024, Return On Capital Employed is likely to grow to 0.03, while Return On Tangible Assets are likely to drop (0.07). At this time, Journey Medical's Intangible Assets are very stable compared to the past year. As of the 25th of April 2024, Intangibles To Total Assets is likely to grow to 0.28, while Non Current Assets Total are likely to drop about 16.4 M. Journey Medical's management efficiency ratios could be used to measure how well Journey Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | COO Age | ||
| Stuart Wilcox | Curaleaf Holdings | 57 | |
Management Performance
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0074 |
Journey Medical Corp Leadership Team
Elected by the shareholders, the Journey Medical's board of directors comprises two types of representatives: Journey Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Journey. The board's role is to monitor Journey Medical's management team and ensure that shareholders' interests are well served. Journey Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Journey Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Young, Chairman of the Board | ||
| Lindsay Rosenwald, Executive Chairman | ||
| Ian Clements, IR Contact Officer | ||
| Lori LyonsWilliams, Chief Commercial Officer | ||
| Christopher Griffith, Co-Founder and VP of Corporate Devel. and Strategy | ||
| Andrew Zwible, Vice Operations | ||
| David Cohen, Independent Director | ||
| Mark McDade, Director | ||
| Robyn Hunter, Treasurer Sec | ||
| Eugene Bauer, Founder, Chief Medical Officer, Director | ||
| Jaclyn Jaffe, Senior Operations | ||
| Jake Nunn, Independent Director | ||
| Frederick Craves, Independent Director | ||
| CPA CPA, Chief Officer | ||
| Ernest Galvan, VP Strategy | ||
| Claude Maraoui, President, Founder | ||
| Ramsey Alloush, General Secretary | ||
| Matthew Fust, Independent Director | ||
| Kathleen Sebelius, Director | ||
| Emmanuel Caeymaex, Director | ||
| Christopher Horan, Chief Technical Operations Officer | ||
| William Ringo, Independent Director | ||
| Joseph Benesch, Interim Controller | ||
| Robert Nevin, Chief Officer | ||
| Luis Pena, Co-Founder and Executive VP of Product Devel. | ||
| Thomas Wiggans, Co-Founder, Chairman and CEO | ||
| Andrew Guggenhime, CFO and COO |
Journey Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Journey Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0074 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 60.85 M | ||||
| Shares Outstanding | 13.93 M | ||||
| Shares Owned By Insiders | 29.91 % | ||||
| Shares Owned By Institutions | 9.72 % | ||||
| Number Of Shares Shorted | 148.09 K | ||||
| Price To Earning | (9.50) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Journey Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Journey Medical's short interest history, or implied volatility extrapolated from Journey Medical options trading.
Pair Trading with Journey Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Journey Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Journey Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Journey Stock
| 0.77 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.75 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.7 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.65 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
| 0.54 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Journey Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Journey Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Journey Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Journey Medical Corp to buy it.
The correlation of Journey Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Journey Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Journey Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Journey Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Journey Stock analysis
When running Journey Medical's price analysis, check to measure Journey Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Journey Medical is operating at the current time. Most of Journey Medical's value examination focuses on studying past and present price action to predict the probability of Journey Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Journey Medical's price. Additionally, you may evaluate how the addition of Journey Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Journey Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 4.343 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0074 | Return On Equity (0.21) |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.